Skip to main content
. 2017 May 16;7:1953. doi: 10.1038/s41598-017-02030-6

Table 1.

Characteristics of patients with severe hyponatremia and neurological symptoms.

Variables All patients Neuroimaging performed No neuroimaging performed P-Value
(n = 140) (n = 95) (n = 45)
Age, in years 66 (55–79) 73 (57–81) 61 (51–76) 0.013
Gender (female in %) 95 (67.9) 70 (73.7) 25 (55.5) 0.032
Vital Signs
  Systolic blood pressure, mmHg 130 (116–146) 140 (126–160) 120 (109–133) 0.007
  Diastolic blood pressure, mmHg 80 (70–90) 80 (70–90) 75 (60–84) 0.115
  Heart frequency/min 80 (67–90) 84 (72–91) 80 (66–90) 0.254
Laboratory Parameters, mmol/l
  Plasma sodium 120 (116–122) 121 (117–122) 119 (116–121) 0.134
  Plasma osmolality 246 (236–257) 245 (236–256) 248 (237–261) 0.512
  Urine sodium 47 (17–90) 62 (20–95) 37 (15–70) 0.032
  Urine osmolality 294 (200–381) 321 (223–430) 252 (170–344) 0.017
Etiology of Hyponatremia, in %
  Diuretics 23.6 23.1 24.4 0.867
  SIAD 31.4 29.4 33.3 0.956
  Cortisol deficiency 5.7 4.2 8.9 0.120
  Hypovolemia 20.0 17.9 26.7 0.232
  Hypervolemia 6.4 2.1 15.5 0.002
  Primary Polydipsia 7.9 8.4 6.7 0.880
  Others 1.4 1.1 2.2 0.586
Neurological symptoms resolved upon hyponatremia treatment 124 (88.6) 79/95 (83.2) 45/45 (100.0) 0.003
  pathological neuroimaging* 1/17 (5.9)
  non-pathological neuroimaging# 78/78 (100)
Door-to-imaging-time, minutes 123 (61–238)

Median and interquartile range reported for continuous variables and frequency; percentage reported for categorical variables. Differences between patients with/without neuroimaging were calculated using the Mann-Whitney U test for continuous variables and the Chi-square test for categorical variables. Two-sided p values < 0.05 were considered statistically significant. SIAD, syndrome of inappropriate antidiuresis (SIAD). *Pathological neuroimaging: neuroimaging showed findings related to acute symptomatology, e.g., ischemic stroke. #Non-pathological neuroimaging: neuroimaging was unremarkable (no incidental/pathological finding) or showed incidental findings not related to acute symptomatology, e.g., general cerebral atrophy, old ischemic stroke.